Skip to main content
Figure 3 | Orphanet Journal of Rare Diseases

Figure 3

From: Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities

Figure 3

Immunohistochemistry and morphoproteomic studies: SPARC (secreted protein acidic and rich in cysteine) is expressed at 2- 3+ in the cytoplasm of the tumor cells. The mammalian target of rapamycin (mTOR) Ser 2448 is expressed up to 2+ in the nuclei of the tumor cells. P-AKT and PDGFR β IHC staining showing an intensity of 2+.

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172